This federal contract award, with ID SPE2DB22D1041|SPE2DB25FTYP7, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,530.49 firm fixed-price delivery order is for the supply of 4,566,566,063 units of the medication Glimepiride 4 mg tablets, with a completion date of November 29, 2024.
The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor, and the award is associated with the company's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 2/26/25, 9:43 AM